<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04846738</url>
  </required_header>
  <id_info>
    <org_study_id>IRBN282021/CHUSTE</org_study_id>
    <nct_id>NCT04846738</nct_id>
  </id_info>
  <brief_title>Transcranial Doppler and Quantitative Pupillometry as Neurological Prognostic Factors in Brain Damaged Patients Admitted to Intensive Care Unit</brief_title>
  <official_title>Comparative Interest of Transcranial Doppler and Quantitative Pupillometry as Neurological Prognostic Factors at 12 Months in Brain Damaged Patients (Stroke or Head Trauma) Admitted to Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transcranial Doppler is performed daily in Intensive Care Unit in brain damaged patients. For&#xD;
      a few years now, the measurement of the photomotor reflex by quantitative Pupillometry has&#xD;
      been routinely performed in Intensive Care Units. The objective of this work is to see if&#xD;
      Transcranial Doppler recorded parameters and Pupillary parameters are correlated to the&#xD;
      neurological prognosis evaluated at 9 months by the Modified Rankin Score (mRS) and the&#xD;
      Glasgow Outcome Scale Extended (GOS-E).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Rankin Score (mRS) (0-5)</measure>
    <time_frame>Year: 1</time_frame>
    <description>Modified Rankin Score (mRS) measures the degree of disability following a stroke in a patient (level 0 for patients with no symptoms to level 5 for patients with major disability and total dependency)..</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glasgow Outcome Scale Extended (GOS-E) (1-8)</measure>
    <time_frame>Year: 1</time_frame>
    <description>Glasgow Outcome Scale Extended (GOS-E) measure the impact of brain injured (minimum at 1 (Dead) and maximum at 8 (Upper Good Recovery).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Systolic Velocity (VMS)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Measured by Transcranial Doppler right and left.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-Cranial Pressure (ICP)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Collect on medical file.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulsatility Index (PI)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Measured by Transcranial Doppler right and left.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tele-Diastolic Velocity (TDV)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Measured by Transcranial Doppler right and left.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basic pupil diameter</measure>
    <time_frame>At inclusion</time_frame>
    <description>Measured by Pupillometry right and left</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of variation of the pupil diameter</measure>
    <time_frame>At inclusion</time_frame>
    <description>Measured by Pupillometry right and left</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Latent and slope of the standard photomotor reflex</measure>
    <time_frame>At inclusion</time_frame>
    <description>Measured by Pupillometry right and left</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue Partial Oxygen Pressure (PtiO2)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Collect on medical file.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bispectral Index (BIS)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Collect on medical file. BIS is a reflection of the depth of hypnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Richmond Agitation-Sedation Scale (RASS)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Richmond Agitation-Sedation Scale (RASS) is a symmetrical rating, with positive values for agitation and negative values for the level of consciousness around a point 0 corresponding to a calm and awake patient.&#xD;
Collect on medical file.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>At inclusion</time_frame>
    <description>Collect on medical file.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>At inclusion</time_frame>
    <description>Collect on medical file.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Natremia (mmol/l)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Collect on medical file.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemia (mmol/l)</measure>
    <time_frame>At inclusion</time_frame>
    <description>Collect on medical file.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Brain Damage</condition>
  <arm_group>
    <arm_group_label>brain damaged patients</arm_group_label>
    <description>All major brain damaged patients (stroke or head trauma) admitted to reanimation will be included.&#xD;
In the usual practice, they have a Transcranial Doppler and the measurement of the photomotor reflex by quantitative Pupillometry.&#xD;
It is planned to collect the simultaneous values of the different parameters during 2,000 measurements.&#xD;
The data will be collected retrospectively from 01/12/2020, and prospectively from 01/04/2021.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Doppler</intervention_name>
    <description>This device measures Mean Systolic Velocity (VMS), Tele-Diastolic Velocity (TDV) and Pulsatility Index (PI),</description>
    <arm_group_label>brain damaged patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pupillometry.</intervention_name>
    <description>This device measures the photomotor reflex (basic pupil diameter, percentage of variation, latent and slope of the standard photomotor reflex)</description>
    <arm_group_label>brain damaged patients</arm_group_label>
    <other_name>AlgiScan</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All brain damaged patients (stroke or head trauma), admitted to Intensive Care Unit since&#xD;
        December 1, 2020&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All brain damaged patients (stroke or head trauma)&#xD;
&#xD;
          -  Admitted to Intensive Care Unit since December 1, 2020&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal by the patient or his/her legal representative.&#xD;
&#xD;
          -  Benefiting from legal protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David CHARIER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU SAINT-ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David CHARIER, MD</last_name>
    <phone>(0)477120485</phone>
    <phone_ext>+33</phone_ext>
    <email>David.Charier@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mathilde PACHCINSKI, Resident</last_name>
    <phone>(0)477120485</phone>
    <phone_ext>+33</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Saint-Etienne</name>
      <address>
        <city>Saint-Ã‰tienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David CHARIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier TESTA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathilde PACHCINSKI, Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Brain injury</keyword>
  <keyword>Transcranial Doppler</keyword>
  <keyword>Quantitative Pupillometry,</keyword>
  <keyword>neurological prognosis</keyword>
  <keyword>modified Rankin Score (mRS)</keyword>
  <keyword>Glasgow Outcome Scale Extended (GOS-E)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

